FDA Rolls Back Lab Test Regulations After Court Vacatur
Published Date: 9/19/2025
Rule
Summary
The FDA is rolling back a recent rule about lab tests done in labs, called Laboratory Developed Tests (LDTs), because a court said so. This means the rules go back to how they were before May 2024. Labs and medical device makers should keep doing what they were doing before, with no new costs or changes for now.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Court vacates May 6, 2024 LDT rule
If you run a lab or make laboratory-developed tests (LDTs), a court vacated the FDA's May 6, 2024 amendment on March 31, 2025. The FDA has reverted the regulation text to how it existed before the May 2024 final rule.
No new costs or changes for now
If you operate a lab or manufacture LDTs, you should continue following the pre-May 2024 rules and expect no new costs or changes for now, per the FDA's implementation of the March 31, 2025 vacatur.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16943, International Association of Color Manufacturers; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by the International Association of Color Manufacturers, proposing that we amend our color additive regulations to provide for the safe use of acetone as a solvent in the manufacture of carrot oil. The petition also proposes to add heavy metal limits and secondary names for carrot oil. FDA may also consider other changes to the regulation, as appropriate, during the course of our review.
Previous / Next Documents
Previous: 2025-18238, Acceleration of Effectiveness of Registration Statements of Issuers With Certain Mandatory Arbitration Provisions
If a company’s registration statement includes a rule that investors must use arbitration to settle disputes, the SEC won’t slow down approving it. Instead, they’ll focus on whether the company clearly explains this arbitration rule in their paperwork. This means companies with these arbitration clauses can get their registrations approved just as fast as others, as long as they’re upfront about it.
Next: 2025-18243, Airspace Designations; Incorporation by Reference Amendments
The FAA is updating its official airspace rules by adding some new changes to a key order, effective September 15, 2025. This affects pilots and air traffic controllers by keeping airspace info fresh and accurate. No extra costs are expected, just smoother skies ahead!